Literature DB >> 12204782

Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.

W Tharnprisarn1, S Taneepanichskul.   

Abstract

This cross-sectional study of bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate was performed to evaluate the differences among these groups. Thirty current OC users and 30 current depot medroxyprogesterone acetate (DMPA) users were included in the study. The mean duration of OC use was 28.8 +/- 3.4 months and of DMPA 24.6 +/- 3.3 months. Dual energy X-ray absorptiometry (DEXA) was used to measure bone mineral density (BMD) at distal and ultradistal forearm of the nondominant side. The BMD of ultradistal forearm of OC users and that of DMPA users were 0.423 +/- 0.048 and 0.403 +/- 0.039 g/cm(2) and at distal forearm of OC and DMPA users were 0.566 +/- 0.043 and 0.571 +/- 0.064 g/cm(2), respectively. However, there were no statistical differences in BMD in these two groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204782     DOI: 10.1016/s0010-7824(02)00330-x

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Relationship between weight and bone mineral density in adolescents on hormonal contraception.

Authors:  Andrea E Bonny; Michelle Secic; Barbara A Cromer
Journal:  J Pediatr Adolesc Gynecol       Date:  2010-08-14       Impact factor: 1.814

Review 2.  Hormonal contraception in adolescents: special considerations.

Authors:  Rollyn M Ornstein; Martin M Fisher
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.

Authors:  Mags E Beksinska; Immo Kleinschmidt; Jenni A Smit; Timothy M M Farley
Journal:  Contraception       Date:  2009-01-17       Impact factor: 3.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.